Ticker	Volume	Price	Price Delta
DJIA	15,335.30	-19.12	-0.12%
S&P 500	1,666.29	-1.18	-0.07%
Nasdaq	3,496.43	-2.53	-0.07%

Ticker

Volume

Price

Price Delta

DJIA

15,335.30

-19.12

-0.12%

S&P 500

1,666.29

-1.18

-0.07%

Nasdaq

3,496.43

-2.53

-0.07%

Ticker	Volume	Price	Price Delta
STOXX 50	2,801.54	-22.96	-0.81%
FTSE 100	6,755.67	+0.04	0.00%
DAX	8,411.16	-44.67	-0.53%

Ticker

Volume

Price

Price Delta

STOXX 50

2,801.54

-22.96

-0.81%

FTSE 100

6,755.67

+0.04

0.00%

DAX

8,411.16

-44.67

-0.53%

Ticker	Volume	Price	Price Delta
Nikkei	15,381.00	+20.21	0.13%
Hang Seng	23,366.40	-126.66	-0.54%
S&P/ASX 200	5,180.06	-28.98	-0.56%

Ticker

Volume

Price

Price Delta

Nikkei

15,381.00

+20.21

0.13%

Hang Seng

23,366.40

-126.66

-0.54%

S&P/ASX 200

5,180.06

-28.98

-0.56%

Croatia’s PharmaS to Make Generic Drugs in Serbia, Novosti Says

By Misha Savic - 2011-11-28T07:48:53Z

PharmaS d.o.o., a Croatian pharmaceutical company, plans an 11 million-euro ($14.6 million) plant in northeastern Serbia, Vecernje Novosti newspaper reported, citing an unidentified person at PharmaS’ Serbian unit.

The plant in Zrenjanin will open by mid-2012, producing generic cardiovascular and gastrointestinal medications, according to the report.

To contact the reporter on this story: Misha Savic in Belgrade at msavic2@bloomberg.net

To contact the editor responsible for this story: James M. Gomez at jagomez@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.